After a pregnant pause, we have started working once more with Ava – the world’s only fertility tracking bracelet. They were keen for us to repeat the success we had for them with their launch last year.
It’s a clinically tested device that uses sensor technology to reveal what’s happening in a woman’s cycle – perfect for women who want to monitor their health for trying to conceive or getting to know their bodies.
Whilst sleeping the Ava’s sensors collect data on nine different physiological parameters and then the Ava’s algorithm detects the woman’s fertile window in real time.
Ava detects the very first signs that the fertile window is beginning, and confirms when it ends. And because Ava is a wearable device, it provides accurate information with minimal user effort. All the wearer must do is sync the bracelet with the app in the morning.
We were bought back in to generate coverage about Ava’s new $30m fundraising round which will enable them to conduct more clinical research and further development into other areas of women’s health.
They also announced that they are currently responsible for the conception of 10,000 babies.
With the funding news embargoed we had time to brief and contact journalists. And once the embargo lifted our results came flooding in.
To date we have 14 key pieces of coverage with more in the pipeline – including one in The Next Web which is due shortly. Also, we know some journalists are planning to use the funding news in a wider feature story about the FemTech sector. We will add these as they appear.
We contacted health and technology journalists for a variety of news outlets. And the first to publish the funding story was Tech Crunch, the world’s most followed start-up funding publication.
This was quickly followed by the Daily Mail, The Telegraph, City AM, Tech eu, Startacus, Tech Buzz Ireland, Fin SMEs, Startup Ticker, Angel News, Venture Canvas, Edition Online, Unquote and Silicon Republic.
Watch this space for further deliveries…
And, there have now been more arrivals following National Fertility Week.
The firstborn was a fertility feature in The Telegraph, followed by a great article in Forbes about the rise of the FemTech market and lastly Yahoo! News picked up and ran the story.
